UPDATE 1-AbbVie to buy Allergan in $63 bln deal

AbbVie Inc said on Tuesday it would acquire Botox-maker Allergan Plc in a cash-and-stock deal for about $63 billion.

Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each share held, for a total consideration of $188.24 per Allergan share.